BioLargo, Inc. (BLGO)
OTCMKTS
· Delayed Price · Currency is USD
0.2300
-0.0020 (-0.86%)
Apr 17, 2025, 4:00 PM EDT
BioLargo Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 17.78 | 12.23 | 5.88 | 2.53 | 2.43 | Upgrade
|
| Revenue Growth (YoY) | 45.37% | 107.85% | 132.48% | 4.07% | 30.68% | Upgrade
|
| Cost of Revenue | 9.93 | 6.08 | 3.03 | 1.43 | 1.2 | Upgrade
|
| Gross Profit | 7.85 | 6.15 | 2.86 | 1.1 | 1.23 | Upgrade
|
| Selling, General & Admin | 9.3 | 8.06 | 6.73 | 6.17 | 7.47 | Upgrade
|
| Research & Development | 2.88 | 2.28 | 1.32 | 1.37 | 1.34 | Upgrade
|
| Other Operating Expenses | - | 0.01 | -0.06 | -0.02 | -0.11 | Upgrade
|
| Operating Expenses | 12.18 | 10.35 | 7.99 | 7.52 | 8.7 | Upgrade
|
| Operating Income | -4.33 | -4.2 | -5.13 | -6.42 | -7.47 | Upgrade
|
| Interest Expense | -0.03 | -0.09 | -0.05 | -0.23 | -1.92 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | 0.04 | 0.07 | 0.06 | 0.14 | Upgrade
|
| EBT Excluding Unusual Items | -4.44 | -4.25 | -5.11 | -6.6 | -9.26 | Upgrade
|
| Asset Writedown | - | -0.39 | -0.2 | -0.34 | - | Upgrade
|
| Other Unusual Items | 0.1 | - | 0.17 | 0.04 | -0.44 | Upgrade
|
| Pretax Income | -4.35 | -4.65 | -5.13 | -6.89 | -9.7 | Upgrade
|
| Earnings From Continuing Operations | -4.35 | -4.65 | -5.13 | -6.89 | -9.7 | Upgrade
|
| Minority Interest in Earnings | 1.95 | 1.14 | 0.66 | -0.19 | 1.27 | Upgrade
|
| Net Income | -2.4 | -3.5 | -4.47 | -7.08 | -8.43 | Upgrade
|
| Net Income to Common | -2.4 | -3.5 | -4.47 | -7.08 | -8.43 | Upgrade
|
| Shares Outstanding (Basic) | 298 | 286 | 268 | 247 | 196 | Upgrade
|
| Shares Outstanding (Diluted) | 298 | 286 | 268 | 247 | 196 | Upgrade
|
| Shares Change (YoY) | 4.25% | 6.58% | 8.54% | 26.13% | 28.87% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 | Upgrade
|
| Free Cash Flow | -4.44 | -2.84 | -3.03 | -3.96 | -4.18 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | Upgrade
|
| Gross Margin | 44.17% | 50.32% | 48.55% | 43.58% | 50.49% | Upgrade
|
| Operating Margin | -24.36% | -34.33% | -87.19% | -253.50% | -307.24% | Upgrade
|
| Profit Margin | -13.51% | -28.65% | -76.02% | -279.73% | -346.71% | Upgrade
|
| Free Cash Flow Margin | -24.98% | -23.25% | -51.55% | -156.38% | -171.75% | Upgrade
|
| EBITDA | -4.18 | -4.1 | -5.09 | -6.4 | -7.41 | Upgrade
|
| EBITDA Margin | -23.49% | -33.49% | -86.42% | -252.71% | - | Upgrade
|
| D&A For EBITDA | 0.16 | 0.1 | 0.05 | 0.02 | 0.06 | Upgrade
|
| EBIT | -4.33 | -4.2 | -5.13 | -6.42 | -7.47 | Upgrade
|
| EBIT Margin | -24.36% | -34.33% | -87.19% | -253.50% | - | Upgrade
|
| Revenue as Reported | 17.78 | 12.23 | 5.88 | 2.53 | 2.43 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.